{"eventGroups":[{"deathsNumAffected":22,"deathsNumAtRisk":41,"description":"First Cycle High-dose (HD) chemotherapy followed by stem-cell infusion (PBPC)\n\nYou will receive 1 dose of Outpatient IV at Bevacizumab 7.5mg/kg.\n\nHD Cycle #1: Gemcitabine/Docetaxel/Melphalan/Carboplatin + PBPC\n\nGemcitabine: 1800 mg/m\\^2 IV over 3 hours on Days -5 to Day -2.\n\nDocetaxel: Docetaxel 300 mg/m\\^2 IV over 2 hours on Day -5.\n\nMelphalan: 50 mg/m\\^2 IV over 15 minutes on Days -4 to Day -2.\n\nCarboplatin: Cycle 1: 333 mg/m\\^2 IV over 2 hours on Days -4 to -2.\n\nStem Cell Transplant: Stem cell infusion on Day 0.\n\nSecond Cycle High-dose (HD) chemotherapy followed by stem-cell infusion (PBPC)\n\nHD Cycle #2: Ifosfamide/Carboplatin/Etoposide + PBPC\n\nCarboplatin: Cycle 1: 333 mg/m\\^2 IV over 2 hours on Days -4 to -2.\n\nCycle #2: 300 mg/m\\^2 IV over 2 hours on Days -6 to -3.\n\nMesna: 3,000 mg/m\\^2 per day in 96-hour continuous infusion, starting 30 minutes prior to the first dose of ifosfamide, on Days -6 to -4.\n\nIfosfamide: 3,000 mg/m\\^2 IV over 6 hours on Days -6 to -3\n\nEtoposide: 200 mg/m\\^2 IV over 3 hours, every 12 hours on Days -6 to -4.\n\nStem Cell Transplant: Stem cell infusion on Day 0.","id":"EG000","otherNumAffected":41,"otherNumAtRisk":41,"seriousNumAffected":7,"seriousNumAtRisk":41,"title":"Cohort 1: HD GeM-DMC+ ICE + Bevacizumab for Refractory GCT"},{"deathsNumAffected":12,"deathsNumAtRisk":23,"description":"First Cycle High-dose (HD) chemotherapy followed by stem-cell infusion (PBPC)\n\nHD Cycle #1: Gemcitabine/Docetaxel/Melphalan/Carboplatin + PBPC\n\nGemcitabine: 1800 mg/m\\^2 IV over 3 hours on Days -5 to Day -2.\n\nDocetaxel: Docetaxel 300 mg/m\\^2 IV over 2 hours on Day -5.\n\nMelphalan: 50 mg/m\\^2 IV over 15 minutes on Days -4 to Day -2.\n\nCarboplatin: Cycle 1: 333 mg/m\\^2 IV over 2 hours on Days -4 to -2.\n\nStem Cell Transplant: Stem cell infusion on Day 0.\n\nSecond Cycle High-dose (HD) chemotherapy followed by stem-cell infusion (PBPC)\n\nHD Cycle #2: Ifosfamide/Carboplatin/Etoposide + PBPC\n\nCarboplatin: Cycle 1: 333 mg/m\\^2 IV over 2 hours on Days -4 to -2.\n\nCycle #2: 300 mg/m\\^2 IV over 2 hours on Days -6 to -3.\n\nMesna: 3,000 mg/m\\^2 per day in 96-hour continuous infusion, starting 30 minutes prior to the first dose of ifosfamide, on Days -6 to -4.\n\nIfosfamide: 3,000 mg/m\\^2 IV over 6 hours on Days -6 to -3\n\nEtoposide: 200 mg/m\\^2 IV over 3 hours, every 12 hours on Days -6 to -4.\n\nStem Cell Transplant: Stem cell infusion on Day 0.","id":"EG001","otherNumAffected":23,"otherNumAtRisk":23,"seriousNumAffected":2,"seriousNumAtRisk":23,"title":"Cohort 2: HD GeM-DMC+ ICE for Refractory GCT"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":41,"numEvents":4},{"groupId":"EG001","numAffected":3,"numAtRisk":23,"numEvents":3}],"term":"ALK increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Allergic reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":41,"numAtRisk":41,"numEvents":70},{"groupId":"EG001","numAffected":22,"numAtRisk":23,"numEvents":22}],"term":"ALT increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":41,"numEvents":6},{"groupId":"EG001","numAffected":2,"numAtRisk":23,"numEvents":2}],"term":"AST increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":37,"numAtRisk":41,"numEvents":37},{"groupId":"EG001","numAffected":14,"numAtRisk":23,"numEvents":14}],"term":"Bacterial"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":41,"numEvents":7},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Bleeding (no GI no PUL)"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"HSCT related microangiopathy (TA-TMA)"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":41,"numEvents":63},{"groupId":"EG001","numAffected":23,"numAtRisk":23,"numEvents":32}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":41,"numEvents":9},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Dysrhythmia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":41,"numEvents":5},{"groupId":"EG001","numAffected":3,"numAtRisk":23,"numEvents":3}],"term":"Confusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":27,"numAtRisk":41,"numEvents":27},{"groupId":"EG001","numAffected":16,"numAtRisk":23,"numEvents":16}],"term":"Creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":41,"numEvents":39},{"groupId":"EG001","numAffected":14,"numAtRisk":23,"numEvents":14}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":41,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":23,"numEvents":2}],"term":"Ejection fraction decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Encephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":35,"numAtRisk":41,"numEvents":35},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Fever"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Flu like syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":41,"numEvents":58},{"groupId":"EG001","numAffected":23,"numAtRisk":23,"numEvents":23}],"term":"Fluid overload"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":41,"numEvents":14},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Fungal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Gastrointestinal bleeding"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":41,"numEvents":87},{"groupId":"EG001","numAffected":23,"numAtRisk":23,"numEvents":35}],"term":"Oral mucositis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":41,"numEvents":8},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":23,"numEvents":2}],"term":"Lower Gl track obstruction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":41,"numEvents":78},{"groupId":"EG001","numAffected":23,"numAtRisk":23,"numEvents":41}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":3,"numAtRisk":23,"numEvents":3}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"GI OTH"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Hallucination"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":41,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Hemorrhagic Cystitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":41,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Hiccups"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Hyperglycemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":41,"numEvents":26},{"groupId":"EG001","numAffected":4,"numAtRisk":23,"numEvents":4}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":36,"numAtRisk":41,"numEvents":36},{"groupId":"EG001","numAffected":13,"numAtRisk":23,"numEvents":13}],"term":"T bilirubin increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Hypoglycemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":41,"numEvents":11},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Palmar-plantar erythrodysesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":41,"numEvents":5},{"groupId":"EG001","numAffected":2,"numAtRisk":23,"numEvents":2}],"term":"Peripheral neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":41,"numEvents":14},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Pulmonary edema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":41,"numEvents":47},{"groupId":"EG001","numAffected":4,"numAtRisk":23,"numEvents":4}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":41,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"renal failure & fluid retention"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":41,"numEvents":19},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Respiratory, thoracic and mediastinal disorders"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"SK DES"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Skin discoloration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":41,"numEvents":63},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Skin Disorders"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Thromboembolic event"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Tremor"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":41,"numEvents":16},{"groupId":"EG001","numAffected":5,"numAtRisk":23,"numEvents":5}],"term":"Viral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"DAH"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":41,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Blurred vision"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":41,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":41,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Somnolence"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":41,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Cystitis noninfective"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"ALT increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"AST increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":41,"numEvents":7},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Bacterial"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":41,"numEvents":4},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Bleeding (no GI no PUL)"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Ejection fraction decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":23,"numEvents":2}],"term":"Creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":41,"numEvents":6},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Fungal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Gastrointestinal bleeding"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Oral Mucositis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":41,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Viral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"Pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":41,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":23,"numEvents":0}],"term":"DAH"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":41,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":41,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":23,"numEvents":1}],"term":"Confusion"}],"timeFrame":"2 years"}